| 商品名 | 申请号 | 产品号 | 申请类型 | 活性成分 | 剂型/给药途径 | 规格/剂量 | RLD | RS | 申请号原始批准/暂定批准日期 | 产品号批准日期 | 申请人 | 市场状态 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PITAVASTATIN CALCIUM | 206015 | 001 | ANDA | PITAVASTATIN CALCIUM | TABLET;ORAL | EQ 1MG BASE | No | No | 2016/12/20 | 2016/12/20 | AUROBINDO PHARMA | Prescription |
| PITAVASTATIN CALCIUM | 206015 | 002 | ANDA | PITAVASTATIN CALCIUM | TABLET;ORAL | EQ 2MG BASE | No | No | 2016/12/20 | 2016/12/20 | AUROBINDO PHARMA | Prescription |
| PITAVASTATIN CALCIUM | 206015 | 003 | ANDA | PITAVASTATIN CALCIUM | TABLET;ORAL | EQ 4MG BASE | No | No | 2016/12/20 | 2016/12/20 | AUROBINDO PHARMA | Prescription |
| PITAVASTATIN CALCIUM | 205932 | 001 | ANDA | PITAVASTATIN CALCIUM | TABLET;ORAL | EQ 1MG BASE | No | No | 2017/02/03 | 2017/02/03 | ORIENT PHARMA CO LTD | Prescription |
| PITAVASTATIN CALCIUM | 205932 | 002 | ANDA | PITAVASTATIN CALCIUM | TABLET;ORAL | EQ 2MG BASE | No | No | 2017/02/03 | 2017/02/03 | ORIENT PHARMA CO LTD | Prescription |
| PITAVASTATIN CALCIUM | 205932 | 003 | ANDA | PITAVASTATIN CALCIUM | TABLET;ORAL | EQ 4MG BASE | No | No | 2017/02/03 | 2017/02/03 | ORIENT PHARMA CO LTD | Prescription |
| PITAVASTATIN CALCIUM | 205955 | 001 | ANDA | PITAVASTATIN CALCIUM | TABLET;ORAL | EQ 1MG BASE | No | No | 2017/02/03 | 2017/02/03 | SAWAI USA | Prescription |
| PITAVASTATIN CALCIUM | 205955 | 002 | ANDA | PITAVASTATIN CALCIUM | TABLET;ORAL | EQ 2MG BASE | No | No | 2017/02/03 | 2017/02/03 | SAWAI USA | Prescription |
| PITAVASTATIN CALCIUM | 205955 | 003 | ANDA | PITAVASTATIN CALCIUM | TABLET;ORAL | EQ 4MG BASE | No | No | 2017/02/03 | 2017/02/03 | SAWAI USA | Prescription |
| PITAVASTATIN CALCIUM | 206070 | 001 | ANDA | PITAVASTATIN CALCIUM | TABLET;ORAL | EQ 1MG BASE | No | No | 2019/04/04 | 2019/04/04 | MYLAN | Prescription |
| PITAVASTATIN CALCIUM | 206070 | 002 | ANDA | PITAVASTATIN CALCIUM | TABLET;ORAL | EQ 2MG BASE | No | No | 2019/04/04 | 2019/04/04 | MYLAN | Prescription |
| PITAVASTATIN CALCIUM | 206070 | 003 | ANDA | PITAVASTATIN CALCIUM | TABLET;ORAL | EQ 4MG BASE | No | No | 2019/04/04 | 2019/04/04 | MYLAN | Prescription |
| PITAVASTATIN CALCIUM | 206047 | 001 | ANDA | PITAVASTATIN CALCIUM | TABLET;ORAL | EQ 1MG BASE | No | No | 2023/02/22 | 2023/02/22 | ZYDUS PHARMS | Prescription |
| PITAVASTATIN CALCIUM | 206047 | 002 | ANDA | PITAVASTATIN CALCIUM | TABLET;ORAL | EQ 2MG BASE | No | No | 2023/02/22 | 2023/02/22 | ZYDUS PHARMS | Prescription |
| PITAVASTATIN CALCIUM | 206047 | 003 | ANDA | PITAVASTATIN CALCIUM | TABLET;ORAL | EQ 4MG BASE | No | No | 2023/02/22 | 2023/02/22 | ZYDUS PHARMS | Prescription |
| PITAVASTATIN CALCIUM | 206029 | 001 | ANDA | PITAVASTATIN CALCIUM | TABLET;ORAL | EQ 1MG BASE | No | No | 2023/11/20 | 2023/11/20 | LUPIN LTD | Prescription |
| PITAVASTATIN CALCIUM | 206029 | 002 | ANDA | PITAVASTATIN CALCIUM | TABLET;ORAL | EQ 2MG BASE | No | No | 2023/11/20 | 2023/11/20 | LUPIN LTD | Prescription |
| PITAVASTATIN CALCIUM | 206029 | 003 | ANDA | PITAVASTATIN CALCIUM | TABLET;ORAL | EQ 4MG BASE | No | No | 2023/11/20 | 2023/11/20 | LUPIN LTD | Prescription |
| PITAVASTATIN CALCIUM | 205977 | 001 | ANDA | PITAVASTATIN CALCIUM | TABLET;ORAL | EQ 1MG BASE | No | No | 2024/04/30 | 2024/04/30 | HETERO LABS LTD V | Prescription |
| PITAVASTATIN CALCIUM | 205977 | 002 | ANDA | PITAVASTATIN CALCIUM | TABLET;ORAL | EQ 2MG BASE | No | No | 2024/04/30 | 2024/04/30 | HETERO LABS LTD V | Prescription |